MoneyWorks4Me

Glenmark Pharmaceuticals informs about withdrawal of issuer rating

23 Sep 2023 Evaluate

Glenmark Pharmaceuticals has informed that, India Ratings has discontinued and withdrawn the outstanding voluntary issuer rating disclosure of the company due to regulatory requirement. All outstanding instrument ratings remain unaffected and this action should not be construed as a change to the credit profile of the Company. The detailed report is attached.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..